ZEB1, a key regulator of EMT, is activated in cancer cells by CCL18 secreted by TAMs, leading to the increased expression of genes involved in extracellular matrix degradation, such as MMP9, and promotes the recruitment of additional TAMs by inducing CCL2 [91,92,93]. Here, ZEB1 is linked to cancer.